Xarelto
The FDA approved Xarelto – generic name rivaroxaban – for use as a blood thinner in 2012. This was big news, as it was the first oral anti-clotting drug to gain approval in nearly 60 years. Bayer HealthCare Pharmaceuticals and Janssen Pharmacetucials, a subsidiary of Johnson & Johnson, jointly market Xarelto. While Xarelto has helped…